[The pharmacodynamics of respiratory stimulants (author's transl)].
D015765:Almitrine; D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D002628:Chemoreceptor Cells / Q000187:drug effects; D004315:Doxapram / Q000494:pharmacology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D010879:Piperazines / Q000494:pharmacology; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects*; D012131:Respiratory Insufficiency / Q000188:drug therapy; D014227:Triazines / Q000494:pharmacology
D000697:Central Nervous System Stimulants; D010879:Piperazines; D014227:Triazines; D011374:Progesterone; D004315:Doxapram; D015765:Almitrine
Pharmacodynamie des stimulants respiratoires.